Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells

被引:234
作者
Chen, Jin-Qiang [1 ,2 ]
Russo, Jose [1 ]
机构
[1] Fox Chase Canc Ctr, Breast Canc Res Lab, Philadelphia, PA 19111 USA
[2] Gold Belt Falcon LLC, Chesapeake, VA 23360 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2012年 / 1826卷 / 02期
关键词
p53; c-Myc; Glucose transporter; Glycolysis; TCA cycle; Glutaminolysis; PYRUVATE-DEHYDROGENASE KINASE; POSITRON-EMISSION-TOMOGRAPHY; INHIBITION-RESISTANT FORM; PENTOSE-PHOSPHATE PATHWAY; ENERGY-METABOLISM; MOLECULAR-CLONING; GLUT1; EXPRESSION; BREAST-CANCER; SDHD GENE; P53-INDUCIBLE REGULATOR;
D O I
10.1016/j.bbcan.2012.06.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A common set of functional characteristics of cancer cells is that cancer cells consume a large amount of glucose, maintain high rate of glycolysis and convert a majority of glucose into lactic acid even in the presence of oxygen compared to that of normal cells (Warburg's Effects). In addition, cancer cells exhibit substantial alterations in several energy metabolism pathways including glucose transport, tricarboxylic acid (TCA) cycle, glutaminolysis, mitochondrial respiratory chain oxidative phosphorylation and pentose phosphate pathway (PPP). In the present work, we focused on reviewing the current knowledge about the dysregulation of the proteins/enzymes involved in the key regulatory steps of glucose transport, glycolysis. TCA cycle and glutaminolysis by several oncogenes including c-Myc and hypoxia inducible factor-1 (HIF-1) and tumor suppressor, p53, in cancer cells. The dysregulation of glucose transport and energy metabolism pathways by oncogenes and lost functions of the tumor suppressors have been implicated as important biomarkers for cancer detection and as valuable targets for the development of new anticancer therapies. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:370 / 384
页数:15
相关论文
共 200 条
  • [11] On the association of succinate dehydrogenase mutations with hereditary paraganglioma
    Baysal, BE
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (10) : 453 - 459
  • [12] Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells
    Beevers, Christopher S.
    Li, Fengjun
    Liu, Lei
    Huang, Shile
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (04) : 757 - 764
  • [13] SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production
    Bell, E. L.
    Emerling, B. M.
    Ricoult, S. J. H.
    Guarente, L.
    [J]. ONCOGENE, 2011, 30 (26) : 2986 - 2996
  • [14] TIGAR, a p53-inducible regulator of glycolysis and apoptosis
    Bensaad, Karim
    Tsuruta, Atsushi
    Selak, Mary A.
    Calvo Vidal, M. Nieves
    Nakano, Katsunori
    Bartrons, Ramon
    Gottlieb, Eyal
    Vousden, Karen H.
    [J]. CELL, 2006, 126 (01) : 107 - 120
  • [15] Cells overexpressing fructose-2,6-bisphosphatase showed enhanced pentose phosphate pathway flux and resistance to oxidative stress
    Boada, J
    Roig, T
    Perez, X
    Gamez, A
    Bartrons, R
    Cascante, M
    Bermúdez, J
    [J]. FEBS LETTERS, 2000, 480 (2-3) : 261 - 264
  • [16] MAXIMUM ACTIVITIES OF KEY ENZYMES OF GLYCOLYSIS, GLUTAMINOLYSIS, PENTOSE-PHOSPHATE PATHWAY AND TRICARBOXYLIC-ACID CYCLE IN NORMAL, NEOPLASTIC AND SUPPRESSED CELLS
    BOARD, M
    HUMM, S
    NEWSHOLME, EA
    [J]. BIOCHEMICAL JOURNAL, 1990, 265 (02) : 503 - 509
  • [17] A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
    Bonnet, Sebastien
    Archer, Stephen L.
    Allalunis-Turner, Joan
    Haromy, Alois
    Beaulieu, Christian
    Thompson, Richard
    Lee, Christopher T.
    Lopaschuk, Gary D.
    Puttagunta, Lakshmi
    Bonnet, Sandra
    Harry, Gwyneth
    Hashimoto, Kyoko
    Porter, Christopher J.
    Andrade, Miguel A.
    Thebaud, Bernard
    Michelakis, Evangelos D.
    [J]. CANCER CELL, 2007, 11 (01) : 37 - 51
  • [18] Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation
    Briere, Jean-Jacques
    Favier, Judith
    Gimenez-Roqueplo, Anne-Paule
    Rustin, Pierre
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 291 (06): : C1114 - C1120
  • [19] PATTERNS AND VARIABILITY OF TUMOR OXYGENATION IN HUMAN SOFT-TISSUE SARCOMAS, CERVICAL CARCINOMAS, AND LYMPH-NODE METASTASES
    BRIZEL, DM
    ROSNER, GL
    PROSNITZ, LR
    DEWHIRST, MW
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (04): : 1121 - 1125
  • [20] BROWN RS, 1993, CANCER, V72, P2979, DOI 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO